$54.73 +0.10 (%) Teva Pharma Ind Shs Sponsored American Deposit Receipt Repr 1 Sh - New York Stock Exchange, Inc.

Jul. 22, 2016 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. California Leads Nation In Tech, Lifesciences IPOs

    IBD | Feb. 12, 2016 | 14:46PM EST
  2. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus | Feb. 9, 2016 | 16:34PM EST
  3. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD | Dec. 30, 2015 | 08:02AM EST
  4. Takeda Provides Update About New Business Venture in Japan with Teva

    Benzinga | Dec. 27, 2015 | 18:02PM EST
  5. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus | Dec. 23, 2015 | 14:24PM EST
  6. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus | Dec. 23, 2015 | 12:13PM EST
  7. Benzinga's Top Initiations

    Benzinga | Dec. 7, 2015 | 09:43AM EST
  8. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD | Dec. 7, 2015 | 08:56AM EST
  9. Benzinga's Volume Movers

    Benzinga | Dec. 3, 2015 | 10:34AM EST
  10. Top Performing Industries For December 1, 2015

    Benzinga | Dec. 1, 2015 | 10:36AM EST
  11. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Nov. 30, 2015 | 07:18AM EST
  12. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs And Mandatory Convertible Preferred Shares In Connection With Pending Acquisition Of Actavis Generics

    Benzinga | Nov. 30, 2015 | 06:54AM EST
  13. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% Stake, Takeda to Own 49% Stake

    Benzinga | Nov. 30, 2015 | 04:22AM EST
  14. Teva, Heptares Announce Agreement to Discover and Develop Novel, Small-Molecule CGRP Antagonists for Treatment of Migraine

    Benzinga | Nov. 25, 2015 | 04:13AM EST
  15. Benzinga's Top Upgrades

    Benzinga | Nov. 23, 2015 | 08:56AM EST
  16. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD | Nov. 22, 2015 | 22:55PM EST
  17. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus | Nov. 17, 2015 | 16:08PM EST
  18. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  19. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD | Nov. 12, 2015 | 12:18PM EST
  20. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus | Nov. 10, 2015 | 17:47PM EST
  21. Teva Announces Breakthrough Therapy Designation for SD-809 Granted by FDA for the Treatment of Tardive Dyskinesia

    Benzinga | Nov. 10, 2015 | 08:06AM EST
  22. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD | Nov. 4, 2015 | 11:58AM EST
  23. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD | Nov. 3, 2015 | 08:02AM EST
  24. Allergan Confirms Pfizer Talks

    IBD | Oct. 29, 2015 | 18:53PM EST
  25. Teva Pharmaceutical's

    IBD | Oct. 29, 2015 | 18:51PM EST
  26. Ah the Joys of Theft - My Purloined Portfolio

    GuruFocus | Oct. 21, 2015 | 17:37PM EST
  27. Here's Why Biotechs Fell On Monday

    Benzinga | Oct. 19, 2015 | 16:29PM EST
  28. Teva Launches Generic Avodart Capsules in the US

    Benzinga | Oct. 12, 2015 | 08:32AM EST
  29. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD | Oct. 8, 2015 | 11:33AM EST
  30. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD | Oct. 5, 2015 | 15:03PM EST
  31. Benzinga's M&A Chatter for Thursday October 1, 2015

    Benzinga | Oct. 1, 2015 | 19:24PM EST
  32. Allergan Guidance Update Gets Mixed Reception

    IBD | Sep. 29, 2015 | 11:39AM EST
  33. U.S. M&A Hits Record As Companies Try To Grow Sales

    IBD | Sep. 28, 2015 | 18:58PM EST
  34. Teva Announces COPAXONE Approved in Japan for Prevention of Relapse of Multiple Sclerosis

    Benzinga | Sep. 28, 2015 | 04:01AM EST
  35. Teva Presents New Reslizumab Data at ERS International Congress 2015

    Benzinga | Sep. 27, 2015 | 06:38AM EST
  36. Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, NICE Systems

    GuruFocus | Sep. 9, 2015 | 17:05PM EST
  37. An ETF That Provides Shelter From Stormy Markets

    Benzinga | Sep. 3, 2015 | 13:33PM EST
  38. Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic transdermal system), First and Only Transdermal Patch System for the Acute Treatment of Migraine

    Benzinga | Sep. 1, 2015 | 08:01AM EST
  39. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents

    Benzinga | Aug. 25, 2015 | 15:05PM EST
  40. Allergan Modestly Tops Views

    IBD | Aug. 6, 2015 | 18:43PM EST
  41. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD | Aug. 6, 2015 | 11:07AM EST
  42. Israeli Tech Startups Attract Record Funding In Q2

    IBD | Aug. 4, 2015 | 13:56PM EST
  43. 5 Top Medical Stocks Reporting Earnings This Week

    IBD | Aug. 3, 2015 | 13:05PM EST
  44. Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga | Aug. 3, 2015 | 10:25AM EST
  45. Benzinga's Top Upgrades

    Benzinga | Aug. 3, 2015 | 09:18AM EST
  46. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD | Aug. 1, 2015 | 08:02AM EST
  47. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD | Jul. 29, 2015 | 18:50PM EST
  48. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD | Jul. 28, 2015 | 20:07PM EST
  49. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD | Jul. 28, 2015 | 16:03PM EST
  50. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD | Jul. 28, 2015 | 14:33PM EST
Trading Center